Daiwa Capital Markets downgraded Illumina from an "outperform" rating to a "neutral" rating and set ...
Illumina Inc. settled for $9.8 million under the False Claims Act, accused of selling cybersecurity-...
A number of stocks jumped in the morning session after positive inflation data fueled hopes for an i...
The United States Personalized Medicine Market is projected to soar to US$ 307.04 billion by 2033 fr...
Vanguard Group Inc. lifted its position in Illumina, Inc. (NASDAQ:ILMN – Free Report) by 3.5% during...